Non-Alcoholic Fatty Liver Disease: The burden of the developed world
Non-alcoholic liver disease (NAFLD) is hepatic steatosis in a patient without a secondary cause for fat accumulation within the liver. What are the clinical manifestations of NAFLD and how should we manage these patients?
MedShr Clinical Leaders new Program Coordinator - Dr Dan Livingstone
Dr Daniel Livingstone appointed as new Program Coordinator for MedShr Clinical Leaders
Matching media queries: